RE: Final overall survival: Fulvestrant 500mg vs 250mg in the randomized CONFIRM trial

  1. Martin, M.
  2. Boyer, J.
  3. Stuart, M.
  4. Di Leo, A.
Journal:
Journal of the National Cancer Institute

ISSN: 1460-2105,  0027-8874

Year of publication: 2017

Volume: 109

Issue: 3

Type: Letter

DOI: 10.1093/JNCI/DJW234 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus